Lecap Asset Management Ltd. purchased a new position in Globe Life Inc. (NYSE:GL – Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 16,951 shares of the company’s stock, valued at approximately $2,233,000.
Other large investors also recently bought and sold shares of the company. Norges Bank purchased a new stake in Globe Life in the fourth quarter worth about $112,454,000. GAMMA Investing LLC boosted its position in shares of Globe Life by 15,553.5% in the 1st quarter. GAMMA Investing LLC now owns 781,890 shares of the company’s stock worth $102,991,000 after purchasing an additional 776,895 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Globe Life in the 4th quarter worth approximately $61,238,000. Freestone Grove Partners LP bought a new position in Globe Life during the 4th quarter valued at approximately $52,178,000. Finally, Marshall Wace LLP increased its position in Globe Life by 1,702.5% during the 4th quarter. Marshall Wace LLP now owns 484,692 shares of the company’s stock valued at $54,053,000 after buying an additional 457,802 shares in the last quarter. 81.61% of the stock is owned by hedge funds and other institutional investors.
Globe Life Stock Up 0.7%
GL opened at $123.00 on Wednesday. Globe Life Inc. has a twelve month low of $80.36 and a twelve month high of $133.76. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43. The firm has a 50 day moving average price of $121.03 and a 200-day moving average price of $119.90. The stock has a market capitalization of $10.15 billion, a price-to-earnings ratio of 10.01 and a beta of 0.56.
Globe Life Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Shareholders of record on Thursday, July 3rd will be given a $0.27 dividend. The ex-dividend date of this dividend is Thursday, July 3rd. This represents a $1.08 annualized dividend and a yield of 0.88%. Globe Life’s payout ratio is 8.79%.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on GL. Wall Street Zen raised Globe Life from a “hold” rating to a “buy” rating in a research note on Friday, May 16th. Piper Sandler dropped their price target on shares of Globe Life from $152.00 to $147.00 and set an “overweight” rating on the stock in a research note on Friday, May 2nd. JPMorgan Chase & Co. increased their price objective on shares of Globe Life from $136.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday, April 2nd. Morgan Stanley raised their price objective on shares of Globe Life from $117.00 to $125.00 and gave the company an “equal weight” rating in a research note on Monday, May 19th. Finally, Wells Fargo & Company dropped their target price on shares of Globe Life from $140.00 to $139.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 6th. Four analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $137.73.
Get Our Latest Stock Analysis on GL
Insiders Place Their Bets
In other Globe Life news, CEO Frank M. Svoboda sold 6,019 shares of the stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $122.51, for a total value of $737,387.69. Following the transaction, the chief executive officer now directly owns 31,298 shares in the company, valued at approximately $3,834,317.98. This trade represents a 16.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.97% of the company’s stock.
Globe Life Profile
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Featured Articles
- Five stocks we like better than Globe Life
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- 3 Hot Trades for Insiders, But Are They Good Buys for Investors?
- Using the MarketBeat Stock Split Calculator
- Why Qualcomm’s Latest Price Target Can’t Be Ignored
- What Are the FAANG Stocks and Are They Good Investments?
- Analyst Sees Meta Hitting $800: What May Lead Shares to New Highs
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.